Physician profile
John Mckinney
NPI 1457330813
$2,382.33
in general payments reported to CMS, 2019-2025
10 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $383 · 2020: $1,840 · 2021: $159.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Edwards Lifesciences Corporation | $1,526.09 | 2020-2021 | |
| Elutia, INC. | $520.30 | 2019-2021 | |
| Clearflow INC. | $119.01 | 2019 | |
| Artivion, INC. | $79.10 | 2019-2020 | |
| Livanova USA, INC. | $39.18 | 2019-2020 | |
| Abbott Laboratories | $33.64 | 2019 | |
| Mallinckrodt Enterprises LLC | $20.31 | 2019 | |
| Zimmer Biomet Holdings, INC. | $18.48 | 2019 | |
| Medtronic Vascular, INC. | $15.17 | 2019 | |
| Csl Behring | $11.05 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Mckinney listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.